First line treatment of aplastic anemia with thymoglobuline in Europe and Asia: Outcome of 955 patients treated 2001-2012

A. Bacigalupo, R. Oneto, H. Schrezenmeier, B. Hochsmann, C. Dufour, S. Kojima, X. Zhu, X. Chen, S. Issaragrisil, S. Chuncharunee, D.C. Jeong, S. Giammarco, M.T. Van Lint, Y. Zheng, C. Vallejo

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)643-648
Number of pages6
JournalAmerican Journal of Hematology
Volume93
Issue number5
DOIs
Publication statusPublished - 2018

Cite this

Bacigalupo, A., Oneto, R., Schrezenmeier, H., Hochsmann, B., Dufour, C., Kojima, S., Zhu, X., Chen, X., Issaragrisil, S., Chuncharunee, S., Jeong, D. C., Giammarco, S., Van Lint, M. T., Zheng, Y., & Vallejo, C. (2018). First line treatment of aplastic anemia with thymoglobuline in Europe and Asia: Outcome of 955 patients treated 2001-2012. American Journal of Hematology, 93(5), 643-648. https://doi.org/10.1002/ajh.25081